Genome MedicineCancer BiologyPeer-reviewed journal article
DNA methylation memory of pancreatic acinar-ductal metaplasia transition state altering Kras-downstream PI3K and Rho GTPase signaling in the absence of Kras mutation
Emily K.W. LoiD, Adrian IdriziiD, Rakel TryggvadóttiriD, Weiqiang ZhouiD, Wenpin HouiD, Hongkai JiiD, Patrick CahaniD, Andrew P. FeinbergiD
Abstract
A critical area of recent cancer research is the emergence of transition states between normal and cancer that exhibit increased cell plasticity which underlies tumor cell heterogeneity. Pancreatic ductal adenocarcinoma (PDAC) can arise from the combination of a transition state termed acinar-to-ductal metaplasia (ADM) and a gain-of-function mutation in the proto-oncogene KRAS. During ADM, digestive enzyme-producing acinar cells acquire a transient ductal epithelium-like phenotype while maintaining their geographical acinar organization. One route of ADM initiation is the overexpression of the Kruppel-like factor 4 gene (KLF4) in the absence of oncogenic driver mutations. Here, we asked to what extent cells acquire and retain an epigenetic memory of the ADM transition state in the absence of oncogene mutation. We identified differential DNA methylation at Kras-downstream PI3K and Rho/Rac/Cdc42 GTPase pathway genes during ADM, as well as a corresponding gene expression increase in these pathways. Importantly, differential methylation persisted after gene expression returned to normal. Caerulein exposure, which induces widespread digestive system changes in addition to ADM, showed similar changes in DNA methylation in ADM cells. Regions of differential methylation were enriched for motifs of KLF and AP-1 family transcription factors, as were those of human pancreatic intraepithelial neoplasia (PanIN) samples, demonstrating the relevance of this epigenetic transition state memory in human carcinogenesis. Finally, single-cell spatial transcriptomics revealed that these ADM transition cells were enriched for PI3K pathway and AP1 family members, linking epigenetic memory to cancer cell plasticity even in the absence of oncogene mutation.
- organism: human
- assay: DNA methylation
- assay: spatial transcriptomics
- research focus: chromatin & epigenetic regulation
- approach: statistical model
- Citations
- 7
- FWCI
- 1.93
- Field percentile
- top 15%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Altered DNA methylation in ion transport and immune signalling genes is associated with severity in Pancreatic Ductal Adenocarcinoma
A. Chatterjee, A. Bararia, … N. Sikdar·bioRxiv·Jun 14, 2021
- Epigenetic plasticity via adaptive DNA hypermethylation and clonal expansion underlie resistance to oncogenic pathway inhibition in pancreatic cancer
L. K. Godfrey, J. Forster, … J. T. Siveke·bioRxiv·May 20, 2022
- Acinar-to-ductal metaplasia in the pancreas requires a glycolytic switch and functional mitochondria
T. Neuss, N. Wirges, … R. M. Schmid·bioRxiv·Jun 27, 2022
- Single-cell transcriptomics reveals a conserved metaplasia program in pancreatic injury
Z. Ma, N. K. Lytle, … K. E. DelGiorno·bioRxiv·Apr 9, 2021
- Dysproteostasis primes pancreatic epithelial state changes in KRAS-mediated oncogenesis
Carla Salomo-Coll, Marisa Di Monaco, … Simon Wilkinson·Developmental CellPeer-reviewed·Aug 15, 2025
- KRAS-mediated upregulation of CIP2A promotes suppression of PP2A-B56α to initiate pancreatic cancer development
S. L. Tinsley, R. A. Shelley, … B. Allen-Petersen·bioRxiv·Jul 1, 2023